Viewpoint Molecular Targeting, Inc. — Form D/A

Viewpoint Molecular Targeting, Inc. of CORALVILLE, IA, a company, filed a Form D amendment with the SEC on 2020-06-18. The offering totals $2.0M, of which $750K was reported sold. Industry: Biotechnology.

Offering

Filed: 2020-06-18
Form: D/A
Accession: 0001768245-20-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $2.0M
Amount sold: $750K
Remaining: $1.3M
Investors: 10
Date of first sale: 2019-02-06
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-333048

Issuer

Name: Viewpoint Molecular Targeting, Inc.
CIK: 0001768245
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 2500 CROSSPARK ROAD E-116, CORALVILLE, IA, 52241
Phone: 8653561861

Officers, directors & promoters (8)

Name	Role	Location
Michael Schultz	Director	LEWES, DE
Michael Schultz	Executive Officer	LEWES, DE
Cameron Gray	Director	Miami, FL
Curtis Nelson	Director	Coralville, IA
Heyward Coleman	Director	Coralville, IA
Heyward Coleman	Executive Officer	Coralville, IA
Frances Johnson	Director	Coralville, IA
Frances Johnson	Executive Officer	Coralville, IA

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2021-01-15	D/A	$15.8M	$14.3M
2020-12-30	D/A	$15.8M	$12.0M
2020-12-04	D	$15.8M	$8.8M
2019-02-19	D	$2.0M	$600K

More